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Background: Genome-wide maps of transcription factor binding sites in primary tissues can expand our
understanding of genome function, transcriptional regulation, and genetic alterations that contribute to disease risk.
However, almost all genome-wide studies of transcription factors have been in cell lines, and performing these
experiments in tissues has been technically challenging and limited in throughput.
Results: Here we outline a simple strategy for mapping transcription factor binding sites in frozen tissues that
utilizes dry pulverization of samples and is scalable for high-throughput analyses. We show that the method leads
to accurate and reproducible chromatin immunoprecipitation next-generation sequencing (ChIP-seq) data, and is
highly sensitive, identifying high-quality transcription factor binding sites from chromatin corresponding to only
5 mg of liver tissue.
Conclusions: The enhanced reproducibility, robustness, and sensitivity of the dry pulverization method, in addition
to the ease of implementation and scalability, makes ChIP-seq in primary tissues a widely accessible assay.
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The assembly of a reference human genome coupled to
the development of novel array and next-generation
sequencing technologies has ushered in an era of high-
resolution approaches for mapping functional genomic
features [1-4], and higher-order nuclear architecture
[5,6]. In particular, cataloging genome-wide binding pro-
files of diverse DNA-binding proteins through next-
generation sequencing of chromatin immunoprecipitated
DNA, or chromatin immunoprecipitation next-generation
sequencing (ChIP-seq) [7,8], has deepened our under-
standing of transcription factor involvement in gene regu-
lation. Although cell lines have played a seminal role in
describing how transcription factors interact with the gen-
ome [1,2,9-13], transcription factor characterization in pri-
mary tissues is a critical next step. While cell models
allow for a focused and controlled biological system that
can be manipulated in a variety of ways, the use of cancer-
derived or transformed cells [14], as well as artificial cul-
ture conditions, can make direct biological inferences
about normal in vivo states challenging. Despite being* Correspondence: rmyers@hudsonalpha.org
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reproduction in any medium, provided the ormore complex and heterogeneous, tissues are derived
from an in vivo context that is subject to physiological
conditions, and therefore the direct analysis of primary
tissues should provide more relevant insights into en-
dogenous biological functions. Indeed, several influential
ChIP-seq studies have been successfully performed in di-
verse mouse tissues [15-18], as well as normal [19] and
diseased [20] human tissue samples. These investigations
have illustrated the power of genomic assays in primary
tissues for characterizing basic cellular functions and the
genomic hallmarks common to disease states.
However, a major barrier to the broader utilization of
ChIP-seq in tissues is that previously published strategies
are much more technically challenging and labor inten-
sive than similar protocols in cell lines. These tissue ap-
proaches have primarily relied on a mincing technique,
wherein adult tissues are diced with a razor prior to fix-
ation and homogenized in a Dounce homogenizer after
fixation [21,22]. This dicing method is technically diffi-
cult and time consuming, making it less tractable for
large-scale projects. The mincing approach can also lead
to substantial sample loss through excessive handling of
the tissue, while cross-contamination concerns diminish
throughput. Importantly, differences in minced tissued. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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neous fixation, which could limit reproducibility, assay
sensitivity and overall data quality. This aspect may be
particularly problematic for rare or scarce tissue sam-
ples. To circumvent the outstanding challenges with
available methods, here we outline a ChIP-seq protocol
for frozen tissue analyses that is simple, efficient, and in-
volves minimal effort, making it easily implementable
and amenable to higher throughput. We find the
method to be robust across diverse tissue types and
highly reproducible for both a general transcription fac-
tor (Rnap2) and sequence-specific factors (Ctcf and
Rxrα). We also determined that our strategy is sensitive,
accurately and reproducibly identifying binding sites
with chromatin amounts that corresponded to only 5
mg of mouse liver (≈675,000 hepatocytes), far lower than
previous protocols demand for liver tissue [21]. The ap-
proach also captures tissue specificity while further re-
capitulating results from previous genomic analyses.
Results
ChIP-seq in mouse tissues
To perform ChIP-seq in frozen tissues while minimizing
tissue handling and cross-contamination concerns, we de-
veloped an approach that uses dry pulverization (Figure 1
and Methods). Tissues are placed in bags that can with-
stand high force and low temperatures and are pulverized
on dry ice while repeatedly being cooled with liquid nitro-
gen. The repeated freezing with liquid nitrogen ensures
that the tissue remains both frozen and brittle, facilitating
the pulverization process. The resulting tissue powder is
fixed with formaldehyde at room temperature and sub-
sequent ChIP experimentation is performed in a man-
ner identical to that in cell lines [23] (see Methods).
Overall, the dry pulverization frozen tissue ChIP-seq
protocol is simple and requires minimal steps, time andFigure 1 Dry pulverization method overview. Tissue is placed in Covari
samples both cold and brittle to facilitate pulverization, tissues are briefly s
pulverization (step 3). Following the pulverization of samples to a powder,
attached Covaris glass vials (step 4). Tissue powder is fixed, washed and stoeffort, making it easily implementable and scalable to
higher throughput analyses. Supporting the enhanced
throughput of the method, all murine samples were
fixed in large batches that consisted of several distinct
tissue sample types, and took approximately one hour
to pulverize and fix.
To evaluate the dry pulverization technique, we tested
mouse liver tissue with antibodies that target RNA poly-
merase II (Rnap2), the insulator CCCTC-binding factor
(Ctcf ) and the Retinoid X receptor α (Rxrα) nuclear re-
ceptor. We chose these factors to determine the feasibil-
ity of our strategy in defining genome-wide maps of
distinct classes of DNA-binding proteins that are widely
expressed in different tissue types, including RNA poly-
merases, canonical transcription factors, and proteins in-
volved in maintaining genome structure.
Using a common set of parameters for pulverization,
fixation, and ChIP for all experiments (see Methods), we
identified thousands of binding sites for Rnap2, Ctcf, and
Rxrα in mouse liver (Figure 2A and Additional file 1:
Table S1). For the sequence-specific factors (Ctcf and
Rxrα), we determined that binding sites were enriched for
their known canonical binding motifs (Figure 2B). We also
performed ChIP analyses with independent biological rep-
licates for each protein and found that more than 87% of
transcription factor binding site overlap between repli-
cates, illustrating the high reproducibility of the method
(Figure 2C and Additional file 1: Table S1). As an
additional validation of the technique, we performed
ChIP-seq to identify CCAAT/enhancer-binding protein
α (Cebpα) transcription factor binding sites, because
this protein has an integral role in hepatic energy me-
tabolism [24], and its binding pattern has been previ-
ously mapped in mouse livers [25], allowing for a direct
comparison. Consistently with the results obtained from
the other factors, we identified highly reproducibles tissueTUBES with adapters and attached glass vials (step 1). To keep
ubmerged in liquid nitrogen (step 2) between successive rounds of
the tissueTUBEs are inverted and tissue powder is collected into
red as a pellet at −80°C.
Figure 2 ChIP-seq in murine liver. (A) ChIP raw sequencing read enrichments for RNA polymerase II (Rnap2), Retinoid X receptor α (Rxrα),
CCAAT/enhancer-binding protein α (Cebpα), and the CCCTC-binding factor (Ctcf) at an apolipoprotein cluster on mouse chromosome 7. (B)
Images of the canonical motifs identified by multiple expectation maximization for motif elicitation (MEME) in liver. (C) Venn diagrams illustrate
the degree of shared binding sites between liver biological replicates.
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(Figure 2B and Additional file 1: Table S1). We also
evaluated the quality of our sequencing libraries by cal-
culating library complexities, or the fraction of aligned
sequences that map to a unique genome location com-
pared with a randomly selected set of 10 million aligned
sequences. For all ChIP experiments, including repli-
cates, we found that our sequencing libraries harbored a
high degree of complexity (Additional file 1: Table S1).
Given the success of the dry pulverization ChIP-seq
protocol in liver, we assessed the performance of the
assay in mouse brain, small intestine, and skeletal
muscle samples with Rnap2, Ctcf, and Rxrα antibodies.
The dry pulverization approach, with identical parame-
ters for pulverization, fixation and ChIP, produced
high-quality ChIP-seq data for each factor across all tis-
sues despite their distinct histology (Additional file 1:
Table S1), highlighting the robustness of the technique.
For sequence-specific factors, the sites we identified
were enriched for their canonical binding motifs (Add-
itional file 2: Figure S1). Like our observations in liver,
our results on binding sites were highly reproducible,
with more than 75% of binding sites being shared be-
tween all pairs of biological replicates (Additional file 1:
Table S1). We also found a high sequence complexity for
all sequencing libraries (Additional file 1: Table S1). Col-
lectively, these data indicate that the dry pulverizationChIP-seq method is robust across distinct tissue types and
can reproducibly identify binding sites for distinct classes
of DNA-binding proteins.
Tissue specificity of genome-wide binding sites
To assess whether the dry pulverization approach can
capture meaningful biological information, we assessed
the functional relevance of the binding data through
intratissue and intertissue analyses. We evaluated the ex-
tent of binding colocalization between the three pre-
dominant DNA-binding proteins that we tested (Rnap2,
Ctcf, and Rxrα) within each tissue (Figure 3A). We
found that a higher proportion of Rxrα binding sites are
shared with Rnap2 than with Ctcf in all tissues examined
(44.8% vs. 6.7% in liver, 42.5% vs. 14.1% in brain, 72.5%
vs. 32.9% in small intestine, 48.5% vs. 1.4% in skeletal
muscle) (Figure 3A). These data are consistent with the
distinct role of Ctcf in chromatin insulation and enhan-
cer blocking [26], while the shared Rnap2/Rxrα sites
may reflect indirect association via binding of Rxrα to
sites near expressed genes and direct associations involv-
ing the recruitment of Rnap2 to promoter-distal Rxrα-
bound enhancer sequences [27,28].
We next performed cross-tissue analyses by determin-
ing the proportion of Rnap2, Ctcf and Rxrα binding sites
that were shared between tissues (Figure 3B and 3C).
Rnap2 and Rxrα binding sites exhibited strong tissue
Figure 3 ChIP-seq analyses across diverse murine tissues. (A) Percentage of Rxrα binding sites shared with Rnap2 (blue), Ctcf (red) or both
Rnap2 and Ctcf (purple) in liver (L), brain (B), small intestine (I) and skeletal muscle (M). Rxrα binding sites that do not colocalize with Rnap2 and
Ctcf are shown in yellow. (B) Analysis of shared binding sites for Rnap2, Rxrα, and Ctcf between all pairwise tissue comparisons. The two tissues
utilized for each comparison are given on the x axis. Shared binding sites are shown in black while tissue-specific sites are in green. (C) ChIP-seq
raw sequencing read enrichments for Rnap2 at distinct genes illustrate tissue specificity of gene expression. Gene names and window sizes are
given above. (D) Canonical motif genomic evolutionary rate profiling (GERP) scores at tissue-specific binding sites (dark red) and binding sites
shared by two (red) or more (orange) tissues. The corresponding motif sequence is shown above the graph. GERP scores are significantly higher within
bound Rxrα motifs relative to positions that are not within a motif but are within 250 bp of a binding site summit (P < 2.2 × 10-16, one-sided t test);
further, there is a highly significant correlation between GERP score and position-specific motif dependencies on a particular nucleotide, with less
degenerate positions being more highly conserved (P < 2.2 × 10-16, simple linear regression between GERP scores and the maximum individual
nucleotide score at each position in the Rxrα motif position-specific weight matrix).
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from 48.5% to 58.4% for Rnap2, and 20% to 68.9% for
Rxrα (Figure 3B); on average, half of the Rnap2 and Rxrα
sites are tissue-specific. In contrast to the tissue specifi-
city of Rnap2 and Rxrα, Ctcf binding was largely similar
across tissues, with typical overlap rates exceeding 90%
between tissue pairs (Figure 3B). In support of these
findings, we also analyzed Rnap2 enrichment at a set of
tissue-specific genes and determined that active tran-
scription was limited to the appropriate tissue type
(Figure 3C). These observations are consistent with pre-
vious studies showing stable Ctcf binding patterns across
cell types [29].We subsequently performed gene ontology analyses
for the binding profiles of Rnap2 and Rxrα. Consistently
with the colocalization results that pointed to pro-
nounced tissue specificity, genes near Rnap2 and Rxrα
binding sites are enriched for distinct biological func-
tions across tissues, and these pathways largely reflect
known processes in each tissue (Additional file 2:
Figures S2 and S3). For instance, Rnap2 binding sites
are enriched for genes related to fatty acid metabolism
in liver and muscle cell development in the muscle,
while genes near Rxrα binding sites in liver are enriched
for lipid and cholesterol metabolic processes, and Rxrα
binding in skeletal muscles enriches for genes involved
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organization.
We also examined sequence conservation at Rxrα
binding sites using genomic evolutionary rate profiling
(GERP) scores [30]. In particular, we assessed the differ-
ence in conservation between canonical motifs at Rxrα
binding sites that are tissue-specific and sites that are
bound by Rxrα in two or more tissues (Figure 3D). The
data show that, while canonical motifs at Rxrα binding
sites are more highly conserved than flanking se-
quences, the degree of conservation is particularly in-
creased at sites bound in multiple tissues. These data
suggest a stronger selective pressure on pleiotropic
binding sites relative to tissue-specific sites. In line with
the canonical motif data, a similar trend in conservation
between tissue-specific and common binding sites is ob-
served when GERP scores are tabulated relative to the
binding site peak summit, whether or not a motif is
present (Additional file 2: Figure S4).
To define the relationship between each factor across
the four tissues that were examined, we looked at the
pairwise Spearman rank correlations of normalized read
depth within a collective list of binding sites (Figure 4).
The resulting correlation matrix captures tissue specificity
as the canonical transcription factors (Rxrα and Cebpα)
and Rnap2 display a correlation primarily driven by tissue
type, while the Ctcf binding patterns form an independent
cluster, further supporting the limited cell-type specificity
of Ctcf binding [29].Figure 4 Correlation matrix between ChIP-seq experiments. Heat map
comparisons for all tissues and ChIPs. Spearman correlations were calculate
sites identified for all ChIP-seq experiments. RNA polymerase II, Pol2; CCCTC-b
protein α, CEBPα.Replication of results from independent genomic datasets
We used publicly available genomic datasets from mouse
tissues, including ChIP-seq, DNaseI hypersensitivity, and
RNA-seq to further evaluate how well our data replicate
previous analyses. We obtained Rnap2 and Ctcf ChIP-
seq data from the Mouse ENCODE Consortium for liver,
brain (by combining cortex and cerebellum datasets)
and small intestine to assess the fraction of binding sites
that are shared [17]. Importantly, these transcription fac-
tor binding site datasets were identified using the min-
cing strategy and therefore allow a direct comparison
with the pulverization method. We determined that our
ChIP-seq results and mouse ENCODE data exhibited
high concordance, as 60 to 75% of Rnap2 binding sites
and 78 to 98% of Ctcf binding sites colocalized between
datasets in the three tissues examined (Additional file 2:
Figure S5). We also evaluated Cebpα binding in liver
and determined that more than 90% of our liver Cebpα
binding sites (19,155 out of 20,467) were identified in an
independent study [25].
Given the lack of available Rxrα ChIP-seq data in mur-
ine tissues, we determined the proportion of Rxrα binding
sites that coincided with diverse epigenetic modifications
identified by the Mouse ENCODE Consortium in liver,
brain (by combining cortex and cerebellum data sets) and
small intestine [17]. For this analysis, we used histone 3
lysine 4 mono-methylation (H3K4me1) marks, as this
modification is found at active chromatin regions and is
associated with regulatory elements [31,32], as well asdisplaying Spearman rank correlations between all pairwise
d using the normalized read depth across the entire set of binding
inding factor, Ctcf; Retinoid X receptor α; Rxrα; CCAAT/enhancer-binding
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cations that are involved in epigenetic silencing [33]. In
line with the identification of putatively active cis-regu-
latory enhancer elements, Rxrα binding sites consist-
ently colocalized with active H3K4me1 marks (84.1% in
liver, 51.4% in brain, and 87.2% in small intestine), in con-
trast with H3K27me3 repressive modifications (1.7% in
liver, 1% in brain, and 1% in small intestine). Confirming
the high ChIP-seq data quality, similar enrichments with
histone modifications were also obtained using Rnap2 and
Ctcf datasets (Additional file 2: Figure S6).
We also calculated the proportion of Rnap2, Ctcf, and
Rxrα binding sites that associated with regions of open
chromatin as identified by DNaseI hypersensitivity [34,35]
from liver, brain, and skeletal muscle tissues performed by
the Mouse ENCODE Consortium. The vast majority of
Rnap2 (83.4%), Ctcf (86.8%), and Rxrα (87.2%) sites across
these three tissues were situated in regions of open chro-
matin (Additional file 2: Figure S7). The degree of back-
ground or non-specific colocalization was also determined
by performing cross-tissue comparisons with ChIP-seq
and DNaseI hypersensitivity datasets. We found a signifi-
cantly stronger enrichment of Rnap2 and Rxrα binding
sites with open chromatin regions from the same tissue
type compared with cross-tissue comparisons (P < 0.05,
two-sided Student’s t test), while Ctcf binding enrichment
with open chromatin was not significantly different be-
tween intratissue and intertissue comparisons, further
confirming the limited tissue specificity of Ctcf [29].
We also used a publicly available RNA-seq dataset
[36] to evaluate the association between Rnap2 ChIP-seq
signal and the level of gene expression. For this analysis,
we determined the normalized read depth for Rnap2 at
gene promoters in liver, brain and skeletal muscle and
correlated these values with gene expression measure-
ments (reads per kilobase per million mapped reads or
RPKMs) in the same tissue (Additional file 2: Figure S8).
Both Rnap2 ChIP-seq replicates from all three tissues
exhibited extensive rank correlation with gene RPKMs
(0.78 in liver, 0.70 in brain, and 0.77 in muscle), suggesting
that our Rnap2 ChIP-seq data at promoters is an accurate
predictor of gene expression levels in the same tissue.
Tissue ChIP-seq input requirements
To measure the sensitivity of the dry pulverization ChIP
method, we performed a titration of mouse liver tissue
by performing ChIP-seq targeting Rxrα. For the titration,
we sonicated 100 mg fixed liver powder and subsequently
performed ChIP-seq on aliquots that corresponded to 50,
25, 10 and 5 mg of tissue. Binding sites that were enriched
for the canonical Rxrα binding motif were identified
across all tissue input amounts (Figure 5A). Based on
previous estimates of hepatocyte number in the mouse
liver [37], these data suggest that our assay can generategenome-wide binding profiles using chromatin from as lit-
tle as ≈675,000 hepatocytes. We determined that each tis-
sue input maintained strong reproducibility, including
92% of binding sites that were shared even between 5 mg
biological replicates (Additional file 1: Table S1). Through
pairwise comparisons between different tissue amounts,
we found that, in each case, more than 90% of binding
sites were concordant (Additional file 2: Figure S9). To
validate these observations further, we looked at Spearman
rank correlations of ChIP-seq signal across tissue amounts
and consistently identified strong correlations (Figure 5B).
As we anticipated, our data exhibited a positive correl-
ation between the number of binding sites identified
and the sample input amount, as increasing amounts of
input chromatin lead to a higher number of binding
sites (Figure 5C). Despite the change in binding sites,
we identified more than 25,000 reproducible Rxrα bind-
ing sites with only a small fraction of chromatin that
represented 5 mg liver tissue. Remarkably, the assay also
retained a high library complexity across all samples
(Additional file 1: Table S1). These results suggest that
the dry pulverization technique is highly robust and can
maximize the number of ChIP-seq experiments performed
on limited or rare amounts of frozen tissue samples, such
as patient samples.
Discussion
While many ChIP-seq analyses have been performed in
cell lines, primary tissues have not been extensively
assayed, even though they may serve as a more appro-
priate model for evaluating biological function in an
organismal context. The labor-intensive and technically
challenging nature of previously described protocols in-
volving tissues is likely to have limited the number of
primary tissue ChIP-seq investigations. Here we have de-
scribed and systematically assessed a dry pulverization
method for efficiently performing ChIP-seq in frozen
mammalian tissues. Importantly, similar pulverization
ChIP-seq strategies have been successfully performed in
Drosophila [38] and Caenorhabditis elegans [39] tissues.
We demonstrate that the pulverization strategy gener-
ates high-quality data and is highly reproducible, with
more than 75% of binding sites being shared across all
biological replicates. Our results are also concordant with
transcription factor binding site ChIP-seq data obtained
using the mincing strategy, as well as DNaseI hypersensi-
tive sites, histone modifications, and gene expression
profiles. However, the advantage of the dry pulverization
method is in its simplicity, requiring minimal effort and
time, thereby making it efficient and adaptable for large-
scale projects. Tissue samples can be pulverized in large
batches and tissue powder can be stored upon pul-
verization, prior to crosslinking, allowing laboratories to
perform these assays in a higher throughput manner. We
Figure 5 ChIP-seq liver titration. (A) Images of the canonical Rxrα motif identified by multiple expectation maximization for motif elicitation
(MEME) for all tissue inputs. (B) Spearman rank correlations between pairwise comparisons using one replicate from each liver input amount. The
upper-right section of the diagram gives the smoothed scatter plot data while the lower-left section displays the rank correlation values, with the
font size corresponding to the strength of correlation. (C) Bar graph displays the total number of binding sites (y axis) shared between biological
replicates for each tissue input amount (x axis).
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consisting of several distinct tissue types, and these took
only 1 hour to perform. The approach also ensures that
tissues remain frozen during the preparation prior to fix-
ation, controlling for potential tissue degradation during
sample preparation. The utilization of tissue powder
rather than diced tissue for fixation ensures a more
homogenous and reproducible fixation, limiting technical
variance that may occur through differences in fixation ef-
ficiency between tissue replicates or across distinct tissue
types. Supporting the advantages of the pulverization
method, we determined that the assay was robust, as we
successfully performed all ChIP-seq assays by relying on a
common set of experimental conditions, despite the differ-
ent histology and physical characteristics of the tissues ex-
amined (see Methods). Collectively, these data suggest
that the dry pulverization method captures both meaning-
ful and accurate biological information, yet involves fewer
steps and less effort than standard protocols.
We also evaluated the sensitivity of dry pulverization
by titrating mouse liver tissue. We demonstrate that the
dry pulverization ChIP-seq method is highly sensitive
and can identify binding sites from chromatin that corre-
sponds to as little as 5 mg liver tissue, or ≈675,000 hepato-
cytes, substantially less than previous recommendations
for liver tissue [21]. The uniform fixation that occurs
through the use of tissue powder may be a contributing
factor for the enhanced sensitivity of the pulverization
method. In light of these observations, dry pulverization is
therefore highly advantageous for handling scarce or lim-
ited tissues, such as clinical samples, as it allows for a largenumber of ChIP-seq experiments to be performed from
one sample. However, the lower limit of input amount will
probably fluctuate between distinct tissues, as this thresh-
old will be dependent on the nuclear density of a given tis-
sue, in addition to antibody quality. The parameters we
used should serve as a starting point for subsequent inves-
tigations and additional optimization of conditions may be
required for unique tissues not assessed in our study.
Although the tissue samples we used for our analyses
weighed at least 200 mg prior to pulverization, obtaining
powder from smaller initial tissue sample amounts with
minimal tissue loss is feasible (see Methods), but down-
stream sonication and immunoprecipitation conditions
may need additional optimization.
The technological advancements over the last decade
have allowed for high-resolution studies of genomic pro-
cesses and these large-scale analyses have led to a deeper
understanding of the complexity involved in gene regu-
lation [1,2,9-13]. However, the validation of phenomena
observed in cells and the delineation of novel functions
in more complex tissues is a critical step for accurately
characterizing endogenous biological processes, and for
defining genomic anomalies in diseased tissues. We be-
lieve that the dry pulverization tissue ChIP-seq approach
outlined in this study can facilitate these important next
steps.
Conclusions
We report a dry pulverization method for ChIP-seq ana-
lysis of frozen tissues that is robust, reproducible and re-
quires minimal input. The simplicity of dry pulverization
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throughput analyses collectively makes tissue ChIP-seq
analyses widely feasible.
Methods
Tissue pulverization and fixation
Tissue samples from C57BL/6J mice at 8 weeks of age
were obtained from Jackson Laboratories. Mice were
cervically dislocated and tissues were dissected and snap
frozen in liquid nitrogen. Tissues were subsequently
stored at −80°C until pulverization. Prior to pulverization,
a hammer and a metallic block were chilled on dry ice for
20 to 30 minutes. During this preparatory cooling, the
metallic block was secured by packing the dry ice around
the block to ensure that it would not move during
pulverization. Frozen tissue samples (≈200 to 800 mg
each) were pulverized in Covaris tissue TUBEs (Covaris
520001) with attached adapters (Covaris 520017) and glass
vials (Covaris 520010). To ensure tissues remained cold
and brittle during pulverization, Covaris tissueTUBEs
were briefly submerged (for ≈5 s) in liquid nitrogen be-
tween successive rounds of pulverization (for ≈10 to 20
seconds) using the chilled hammer on the cold metallic
block. The tissueTUBE was gently tapped so all tissue
matter was collected at the bottom of the bag prior to
each pulverization. To ensure that the tissue was fully
pulverized, we briefly examined the tissue sample
within the transparent tissueTUBE. Typically, complete
pulverization takes about 5 to 10 rounds of pul-
verization, depending on tissue makeup and histology.
Once the tissue had been pulverized to a powder, the
tissueTUBEs were inverted and tissue powder was
collected into attached Covaris glass vials. The subse-
quent tissue powder was resuspended in room tem-
perature PBS containing protease inhibitors (Roche
11836153001) and transferred to a 15 ml conical tube.
Additional room temperature PBS containing protease
inhibitors was added to 15 ml conical tubes to a final
volume of 10 ml and tissue powder was crosslinked
with 1% formaldehyde for 15 minutes while rocking at
room temperature. After fixation, the crosslinking reac-
tion was halted using 0.125 M glycine for 5 minutes
while rocking at room temperature. Crosslinked tissue
powder was pelleted (750 relative centrifugal force for
5 minutes at 4°C) and washed three times with cold
(4°C) PBS containing protease inhibitors. After each
wash, crosslinked tissue powder was pelleted. Following
washing, the pelleted tissue powder was subsequently
stored at −80°C. For smaller tissue samples (less than
200 mg), the initial preparation and pulverization
should be performed as outlined above. However, the
resulting tissue powder should be resuspended with
PBS containing protease inhibitors directly within the
tissueTUBE, without inverting, to prevent tissue loss.The tissue solution should then be placed in an appro-
priately sized container and fixed with 1% formalde-
hyde for 15 minutes.
Chromatin immunoprecipitation and next-generation
sequencing
Antibodies for RNA polymerase II (ab5408, abcam),
Rxrα (sc-553, Santa Cruz Biotechnology), Ctcf (sc-5916,
Santa Cruz Biotechnology and 61312, Active Motif ),
and Cebpα (sc-166258, Santa Cruz Biotechnology) were
obtained and the ChIP assay and subsequent sequen-
cing library preparations were conducted as previously
reported [23]. The Ctcf Active Motif antibody was used
for small intestine and the Ctcf sc-5916 antibody was
utilized for the remaining three tissues. Sonication was
performed with a Sonics Vibracell at 60% amplitude on
100 mg aliquots of fixed tissue powder using six total
30-second durations of sonication for all tissues. All
ChIP libraries were run on an Illumina HiSeq 2000 se-
quencer using 50 bp single-end sequencing.
Data analysis
Sequencing reads were aligned to the genome using Bowtie
[40] and binding sites were identified using the model-
based analysis of ChIP-Seq (MACS) peak caller with an
mfold cutoff of 15 [41]. All position weight matrices were
identified using multiple expectation maximization for
motif elicitation (MEME) [42]. Normalized read depths for
examining Spearman rank correlations between ChIP-seq
experiments were calculated by merging 100-bp binding
sites centered on peak summits for all experiments and de-
termining the number of sequencing reads mapping to the
entire list of binding sites and normalizing these values by
the total number of reads that were mapped for each ChIP
experiment (that is, reads per million). For RNA polymer-
ase II promoter analyses, we determined the normalized
read depth at a 2-kb region of sequence centered on the
transcription start site for all expressed genes detected by
RNA-seq. To calculate the fraction of binding sites shared
between ChIP-seq experiments, we divided the number of
sites that overlapped by the number of sites identified in
the smaller ChIP-seq dataset. Evolutionary conservation of
motifs was determined by identifying all Rxrα canonical
motif position weight matrices within Rxrα-bound sites
across all tissues. GERP scores were cataloged for all base
positions within the position weight matrix, and binding
sites harboring motifs were compared across tissues to
determine tissue specificity. For binding site conserva-
tion of sites within all peaks regardless of motif presence
(Additional file 2: Figure S4), the average GERP scores
for each position within a 200-bp fragment of DNA
centered on peak summits was used. To determine se-
quencing library complexity, we calculated the fraction
of uniquely mapped reads from a randomly selected
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genome. Statistical significance was determined with a
one- or two-sided Student’s t test.
Additional files
Additional file 1: Summary of ChIP-seq data. Table summarizing
ChIP-seq experimentation across all mouse tissues. The percentage of
sites shared was calculated by dividing the number of shared sites by the
number of sites from the biological replicate with a smaller number of
identified sites.
Additional file 2: Figure S1. Canonical motifs identified in brain, small
intestine, and skeletal muscle tissue samples. Figure S2. GO biological
process analysis for RNA polymerase II ChIP-seq. Figure S3. GO biological
process analysis for retinoid X receptor ChIP-seq. Figure S4. Conservation
scores relative to Rxrα binding site summit. Figure S5. Analysis of ChIP-seq
with Mouse ENCODE transcription factor binding site data. Figure S6.
Analysis of ChIP-seq with Mouse ENCODE transcription histone modification
data. Figure S7. Analysis of ChIP-seq with open chromatin annotations.
Figure S8. Correlation between Rnap2 promoter enrichment and RNA-seq
gene expression data. Figure S9. Rxrα binding site colocalization across
different liver tissue inputs.
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